Experimental drug enhances immunotherapy against pancreatic cancer in mice
A combination treatment that included an experimental small molecule drug not only led to a reduction in tumor growth in murine models of pancreatic cancer, but it also eliminated the cancer in some mice. The findings were published in the Journal for ImmunoTherapy of Cancer on November 4. Read More
IsoPlexis to present data at SITC 2021
IsoPlexis will present data from its IsoLight and IsoSpark platforms at the annual meeting of the Society for Immunotherapy of Cancer (SITC) on November 11 virtually and in person at the Walter E. Washington Convention Center in Washington, DC. Read More
Scientists explain non-small cell lung cancer treatment resistance
A research group has shown why certain T cells do not respond to therapy in patients with non-small cell lung cancer who receive a therapy called immune checkpoint blockade. The findings, published on October 29 in Science Immunology, suggest that a combination of immunotherapies may be a more effective approach to treating lung cancer. Read More
Akoya welcomes founding members of Imaging Innovators Network
Akoya Biosciences has selected the founding members of its new Imaging Innovators Network. Read More
Filling a gap so biotech startups can advance to the next level
In the biotechnology industry, there is a need for capital among companies that are already commercial and have products with demonstrated success but that might not yet be profitable. BroadOak Capital fills the gap for biotech companies between venture capital and private equity, according to partner Bill Snider who spoke with ScienceBoard.net. Read More
Polaris Biology launches a new mass cytometer
Polaris Biology has released a new mass cytometry system called Starion. The cytometer allows for analysis of more than 40 parameters at a single-cell resolution. Read More
10x Genomics opens Singapore manufacturing facility
10x Genomics has opened a manufacturing and commercial facility in Singapore, expanding its reach into the Asia-Pacific region. The facility is the company's first outside of the U.S. Read More
New platform identifies best viral vectors for gene therapy
Researchers have developed a novel computational platform that identifies the best viral vector to deliver a gene therapy to its target. The technology, described October 19 in eLife, promises to speed development of adeno-associated virus-mediated gene therapies against vision loss and other disorders. Read More
PerkinElmer, Honeycomb launch single-cell isolation and analysis tool
PerkinElmer and Honeycomb Biotechnologies have launched a new single-cell isolation and analysis tool called Hive scRNAseq. Read More
IsoPlexis raises $125M in IPO
IsoPlexis completed an initial public offering (IPO) on October 12, closing with $125 million on the sale of approximately 8.3 million shares at $15 per share. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter